// App-Quantinova.ai

BSH19‐PO‐088 : Switched memory B‐cells as a marker for identifying haemato‐oncology patients who require immunoglobulin replacement therapy for secondary immunodeficiency

Researchers

Presenter

  • A. Shields

Principal Investigators

  • R. Anderson

  • N. McCarthy

  • A. Richter

Medical Centers

  • Clinical Immunology Service, University of Birmingham, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Hypogammaglobulinaemia

Biomarkers

  • Cluster of Differentiation 19

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A